Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle
Related Experiment Video
Updated: Aug 6, 2026

Preparation and Culture of Myogenic Precursor Cells/Primary Myoblasts from Skeletal Muscle of Adult and Aged Humans
Published on: February 16, 2017
Erik Edström1, Mikael Altun, Martin Hägglund
1Department of Neuroscience, Karolinska Institutet, Neuroscience, A3:4, Stockholm, Sweden 17177. erik.edstrom@ki.se
Abstract:
Muscle atrophy in many conditions share a common mechanism in the upregulation of the muscle-specific ubiquitin E3-ligases atrophy gene-1/muscle atrophy F-box (Atrogin-1/MAFbx) and muscle ring-finger protein 1 (MuRF1). E3-ligases are part of the ubiquitin proteasome pathway utilized for protein degradation during muscle atrophy. In this study, we provide new data to show that this is not the case in age-related loss of muscle mass (sarcopenia). On the contrary, Atrogin-1/MAFbx and MuRF1 are downregulated in skeletal muscle of 30-month-old rats, and our results suggest that AKT (protein kinase B)-mediated inactivation of forkhead box O 4 (FOXO4) underlies this suppression. The data also suggest that activation of AKT is mediated through the insulin-like growth factor-1 (IGF-1) receptor, signaling via ShcA-Grb2-GAB. Using dietary restriction, we find that it impedes sarcopenia as well as the effects of aging on AKT phosphorylation, FOXO4 phosphorylation, and Atrogin-1/MAFbx and MuRF1 transcript regulation. We conclude that sarcopenia is mechanistically different from acute atrophies induced by disuse, disease, and denervation.
Insights
Age-related muscle loss (sarcopenia) differs from other forms of atrophy. Key muscle-degrading proteins Atrogin-1/MAFbx and MuRF1 are downregulated in sarcopenia, contrary to other atrophy conditions.
Area of Science:
- Muscle physiology
- Aging research
- Molecular biology
Background:
- Muscle atrophy involves ubiquitin E3-ligases like Atrogin-1/MAFbx and MuRF1.
- These ligases are crucial for protein degradation in muscle wasting conditions.
Purpose of the Study:
- To investigate the role of Atrogin-1/MAFbx and MuRF1 in age-related muscle loss (sarcopenia).
- To explore the underlying molecular mechanisms, including AKT and FOXO4 signaling, in sarcopenia.
- To assess the impact of dietary restriction on sarcopenia and related molecular pathways.
Main Methods:
- Analysis of Atrogin-1/MAFbx and MuRF1 expression in aged rats.
- Investigation of AKT and FOXO4 phosphorylation status.
- Assessment of IGF-1 receptor signaling pathway components (ShcA-Grb2-GAB).
- Evaluation of dietary restriction effects on molecular markers and muscle mass.
Main Results:
- Atrogin-1/MAFbx and MuRF1 were downregulated in sarcopenic rat skeletal muscle.
- Downregulation correlated with increased AKT and FOXO4 phosphorylation, suggesting AKT-mediated FOXO4 inactivation.
- Insulin-like growth factor-1 (IGF-1) receptor signaling appeared to mediate AKT activation.
- Dietary restriction attenuated sarcopenia and prevented age-related changes in AKT/FOXO4 phosphorylation and gene regulation.
Conclusions:
- Sarcopenia exhibits distinct molecular mechanisms compared to acute atrophy (disuse, disease, denervation).
- Age-related muscle loss is characterized by suppressed, not upregulated, Atrogin-1/MAFbx and MuRF1.
- AKT/FOXO4 pathway inactivation and IGF-1 signaling are implicated in sarcopenia.
- Dietary restriction offers a potential intervention strategy against sarcopenia.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The Effect of Aging on Tissues
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Cross-bridge Cycle
Master Transcription Regulators
Cellular Adaptation I: Introduction and Atrophy

